Cogent Biosciences Appoints Accomplished Finance Executive Todd E. Shegog to its Board of Directors - biospace.com -BoardProspects

Cogent Biosciences Appoints Accomplished Finance Executive Todd E. Shegog to its Board of Directors

biospace.com Feb 22 2021 BoardMoves

CAMBRIDGE, Mass., Feb. 22, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Todd E. Shegog to its Board of Directors...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Target CEO Gregg Steinhafel Resigns In Data Breach Fallout also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Blueprint Medicines (BPMC) Appoints Lynn Seely, MD to Board of Directors also published in biospace.com
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Alzheon Appoints Dennis H Langer MD JD To Board Of Directors also published in biospace.com
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Immune Pharma Names Dr. Jeff Paley To Its Board Of Directors also published in biospace.com

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
Topics Mentioned